A 65-year-old patient diagnosed in another surgical service with lower rectal adenocarcinoma (approximately 3 cm from the external anal orifice) with mixt pattern (mucin + ring cells ), stenotic, cT4bN1M0, where she follows the following therapeutic route. In the first therapeutic time, surgery is performed in another center, laparoscopically with a Mayo-Reeves colostomy. On the oncological line it was performed FOLFOX regim and radiotherapy , with imaging reassessment (appreciates stable disease). Surgery is performed by median laparotomy and pelvic-abdominal peritoneal carcinomatosis is found (PCI Sugarbacker Index = 18), an unresectable pelvic tumor block, mucinous ascites; Second line of chemotherapy (Irinotecan+FOLFIRI) is instituted with subsequent imaging reassessment (PR> 30%); The patient is transferred to our surgery department, where we decide according to the MDT the following therapeutic approach:
